Michael G. Fehlings PhD, MD, FACS, FRCSC

Dr. Fehlings is the Medical Director of the Krembil Neuroscience Center and heads the Spinal Program at the Toronto Western Hospital. Dr. Fehlings is a Professor of Neurosurgery at the University of Toronto, holds the Halbert Chair in Neural Repair and Regeneration, a Scientist at the McEwen Centre for Regenerative Medicine, and a McLaughlin Scholar in Molecular Medicine. In the fall of 2008, Dr. Fehlings was appointed the inaugural Director of the University of Toronto Neuroscience Program and Co-Director of the newly formed University of Toronto Spinal Program. In 2014, he was elected as a Fellow of both the Royal Society of Canada and the Canadian Academy of Health Sciences.

Dr. Fehlings combines an active clinical practice in complex spinal surgery with a translationally oriented research program focused on discovering novel treatments for spinal cord injury. This is reflected by the publication of over 300 peer-reviewed articles chiefly in the area of spinal cord injury and complex spinal surgery.

Dr. Fehlings leads a multi-disciplinary team of researchers, which is examining the application of stem cells, nanotechnology, and tissue engineering for spinal cord repair and regeneration. He is also a principal investigator in the Christopher and Dana Reeve Foundation North American Clinical Trials Network, is co-chair of the internationally renowned Spine Trauma Study Group and leads several international clinical research efforts through AOSpine.